Please login (Members) to view content or
(Nonmembers) this article.
0
No votes yet
Advanced Practice Nursing Issues

Epstein-Barr Virus Infection and Lymphoproliferative Disorder After Hematopoietic Cell Transplantation

Yazhen Zhong
CJON 2012, 16(2), 211-214 DOI: 10.1188/12.CJON.211-214

Common herpes viruses such as Epstein-Barr virus (EBV) cause infection and disease after hematopoietic cell transplantation (HCT). Post-transplantation lymphoproliferative disorder following allogeneic HCT is a rare but life-threatening disease, mostly associated with EBV-infected B cells. Anti-CD20 monoclonal antibodies (e.g., rituximab) target normal and infected B cells and further suppress the patient's immune system. This article describes the development of cellular therapies by infusing virus-specific cytotoxic T lymphocytes via IV into patients to create an adoptive immune system for specific viral suppression.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or